Mitsubishi Gas Chemical Company, Inc. 4182
TSE · Japonya · Proses Endüstrileri
¥3.920,00+36,00 (+%0,93)
Piyasa kapalı· · JPY · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · JPY · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Brookfield Asset Management (NYSE:BAM) has agreed to invest up to $600 million in India’s ACME Cleantech Ventures to support the development and construction of green ammonia and green methanol projects, the companies announced on Thursday. The investment marks Brookfield’s entry into the region’s low-carbon fuels sector and will be made through its Brookfield Global Transition Fund strategy.
Why Mitsubishi Gas Chemical Company (TSE:4182) is on investors’ radar today Mitsubishi Gas Chemical Company (TSE:4182) has drawn attention after recent share price moves, with the stock up about 10% over the past 3 months and a year to date return above 70%. See our latest analysis for Mitsubishi Gas Chemical Company. Short term share price momentum has cooled after earlier gains, with the stock roughly flat over the past month but still showing a 19.1% 90 day share price return and strong 1...
GlycoNex, Inc. (4168, hereinafter referred to as GNX), today announced that the Phase III clinical trial for SPD8, a Denosumab biosimilar co-developed with Mitsubishi Gas Chemical, has successfully met its primary endpoint. Statistical analysis confirms that SPD8 demonstrated therapeutic equivalence to the reference drug, Prolia® (marketed as Pralia® in Japan). The company expects to finalize the clinical study report by the end of September, followed by a drug approval application in Japan. Jap
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.